Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Aligos Therapeutics $150 million IPO
Davis Polk advised  the representatives of the several underwriters in connection with the $150 million initial public offering of 10,000,000 shares of common stock of Aligos…
Eargo $165.2 million IPO
Davis Polk advised the representatives of the several underwriters in connection with an initial public offering of 9,029,629 shares of common stock of Eargo, Inc. at $18.00 per share …
H.B. Fuller $300 million notes offering
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered debt issuance by H.B. Fuller Company of $300 million of its 4.250% notes due 2028…
Royalty Pharma $728 million secondary offering
Davis Polk advised Royalty Pharma plc and the selling shareholders on Royalty Pharma’s $728 million secondary offering of 17,343,037 of its Class A ordinary shares by certain selling…
Turmeric Acquisition $97.75 million IPO
Davis Polk advised the joint book-running managers in connection with the $97.75 million initial public offering of 9,775,000 units of Turmeric Acquisition Corp., which includes 1,275…
Array Technologies $1.2 billion IPO
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $1.2 billion initial public offering of 54,625,000 shares of common…
Chaparral Energy emergence from chapter 11 bankruptcy
Davis Polk has served as lead counsel to Chaparral Energy, Inc. and its subsidiaries throughout their chapter 11 proceedings. On October 1, 2020, the U.S. Bankruptcy Court for the District…
Cboe Global Markets acquisition of BIDS Trading
Davis Polk is advising Cboe Global Markets on its acquisition of BIDS Trading, a registered broker-dealer and the operator of the BIDS Alternative Trading System. The transaction is…
Back to top